News Releases | Lucira Health, Inc

Year

29 Nov '21

Lucira's at Home Molecular Tests Can Detect Omicron (B.1.1.529) SARS CoV-2 Variant of Concern

Lucira assessment confirms COVID-19 Check-It (OTC) and All-In-One (Rx) molecular self-test kits' ability to detect 100% of Omicron variant genome sequences analyzed Lucira assays target viral sequence regions unaffected by the spike protein mutations found in Omicron, Delta and other Variants of

11 Nov '21

Lucira Health Announces Third Quarter 2021 Financial Results and Provides Business Update

EMERYVILLE, Calif., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported

09 Nov '21

LUCIRA™ CHECK IT PCR Quality, at Home Molecular COVID-19 Test Kit Now Available on Amazon

This FDA Emergency Use Authorization ("EUA") first PCR quality, single-use, COVID-19 at home, self-test kit is available for purchase by Amazon customers in the United States EMERYVILLE, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a

28 Oct '21

Lucira Health to Announce Third Quarter 2021 Financial Results

EMERYVILLE, Calif., Oct. 28, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced that the company will report third

26 Oct '21

LUCIRA™ CHECK IT COVID-19 Test Kit is Available for Online Purchase

This FDA Emergency Use Authorization (“EUA”) first PCR quality, single-use, COVID-19 at home, self-test kit can again be purchased via the Company’s website EMERYVILLE, Calif., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health" or "Lucira") (Nasdaq: LHDX), a medical technology

12 Oct '21

LUCIRA™ HEALTH COVID-19 Test Approved for Sale in Singapore

Singapore Health Sciences Authority issues approval by its Pandemic Special Access Route (PSAR) for the LUCIRA CHECK IT COVID-19 Test Kit. Lucira has partnered with Labgistics Asia Pte Ltd for the importation and distribution of its products in Singapore. EMERYVILLE, Calif., Oct.

08 Oct '21

LUCIRA™ HEALTH Provides Statement on Copan’s Recall of its FLOQSwabs

EMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today commented on the recent recall

20 Sep '21

LUCIRA™ HEALTH Hires Tony Allen as Chief Operations Officer

Veteran operations expert joins Lucira’s management team EMERYVILLE, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious

23 Aug '21

LUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory Affairs

Life science professional expands Lucira’s management team EMERYVILLE, Calif. --(BUSINESS WIRE)--Aug. 23, 2021-- Lucira Health, Inc. (“ Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative

12 Aug '21

Lucira Health Announces Second Quarter 2021 Financial Results

EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today reported

Pagination

Current page 1
Page 2
Page 3
Next page
Last page

Displaying 1 - 10 of 25